The largest database of trusted experimental protocols

6470 series triple quadrupole mass spectrometer

Manufactured by Agilent Technologies
Sourced in United States

The Agilent 6470 Series Triple Quadrupole mass spectrometer is a high-performance analytical instrument designed for sensitive and accurate mass analysis. It utilizes triple quadrupole technology to provide precise quantitative and qualitative analysis of chemical compounds. The 6470 Series delivers reliable and reproducible results for a wide range of applications.

Automatically generated - may contain errors

6 protocols using 6470 series triple quadrupole mass spectrometer

1

Targeted Metabolomics Analysis of Frozen Brain Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Metabolites from powderized flash-frozen brain tissue were extracted in ice-cold 80% methanol. Subsequently, extract from the equivalent of 1 mg tissue was dried down in a room temperature speed-vac for metabolomics analysis. Metabolites were resolved using reverse phase ion-paired chromatography on an Agilent 1290 Infinity II Series LC and detected by MRM in negative ion mode on an Agilent 6470 series triple quadrupole mass spectrometer. The liquid chromatography–tandem mass spectrometry (LC–MS/MS) targeted MRM method used for metabolomics analysis was developed and implemented by Agilent Technologies.
+ Open protocol
+ Expand
2

Enzymatic Inhibition of hMAO-A and hMAO-B

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hMAO-A and hMAO-B enzymes were purchased from Sigma-Aldrich (St. Louis, MO, USA). The reaction mixture contained hMAO-A (2.5 µg/mL protein final concentration) or hMAO-B (6.25 µg/mL protein final concentration) enzyme and tested compound in final concentration of 1 and 10 µM in 50 mM potassium phosphate buffer with 20% (v/v) glycerol (pH 7.5). The mixture was pre-incubated at 37 °C for 5 min and subsequently substrate kynuramine was added to the final concentration of 60 µM in the case of hMAO-A and 30 µM in the case of hMAO-B. The final volume of reaction mixture was 0.1 mL. The whole reaction mixture was incubated at 37 °C for 30 min. The reaction was stopped by the addition of 200 µL acetonitrile/methanol mixture (ratio 1:1) and cooling down to 0 °C. The sample was then centrifuged (16.500× g) for 10 min. The deamination product of kynuramine formed during the enzymatic reaction 4-hydroxyquinoline (4-HQ) was determined by HPLC–MS on a 2.1 mm × 50 mm, 1.8 µm Zorbax RRHD Eclipse plus C18 column (Agilent) by using a 6470 Series Triple Quadrupole mass spectrometer (Agilent) (electrospray ionisation – positive ion mode). Three MRM transitions were followed for kynuramine (165.1 = > 30.2, 165.1 = > 118.0, 165.1 = > 136.0) and 4-HQ (146.1 = > 51.1, 146.1 = > 77.0, 146.1 = > 91.0). Eluents: (A) 0.1% formic acid in water; (B) 0.1% formic acid in acetonitrile.
+ Open protocol
+ Expand
3

Quantification of Sugar Compounds in Plant Leaves

Check if the same lab product or an alternative is used in the 5 most similar protocols
An aliquot of fresh leaves (300 mg) was homogenized in 80% ethanol and heated at 80 °C for 20 min. The homogenate was centrifuged at 4500 rpm for 10 min. The supernatant was collected in a clean tube, the pellet was resuspended in 50% ethanol and reheated at 80 °C for 20 min. After centrifugation, the supernatants were pooled. This step was repeated once more. The content of sugars (glucose, fructose, sucrose) and sugar alcohols (sorbitol, glycerol) in the combined supernatants determined using UHPLC Infinity II 1290 system (Agilent Technologies, Santa Clara, CA, USA) using a 6470 Series Triple Quadrupole mass spectrometer (Agilent Technologies; electrospray ionization, negative polarity) as detector. The method used a BEH Amide column (2.1 mm × 150 mm, 2.6 µm, Waters, Milford, MA, USA). An isocratic elution program was used for chromatographic separation applying mobile phase comprising 20:80% mixture of 0.05% formic acid in water and 8:2 acetonitrile/methanol mixture. The flow rate was 0.4 mL min−1. Ion source parameters: gas temperature 150 °C, gas flow 6 L min−1, nebulizer 40 psi, sheath gas temperature 300 °C, sheath gas flow 128 L min−1, capillary voltage 2500 V, and nozzle voltage 0 V. The sample injection volume was 1 µL. All standards used were purchased from Sigma Aldrich (Darmstadt, Germany).
+ Open protocol
+ Expand
4

Quantitative Analysis of Phenolic Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
The contents of phenolic acids were determined by UHPLC on Zorbax RRHD Eclipse plus C18 column (2.1 × 50 mm, 1.8 µm) (Agilent) with a 6470 Series Triple Quadrupole mass spectrometer (Agilent) (electrospray ionization in negative ion mode) as a detector. Eluents: (A) 0.05% formic acid in water and (B) 0.05% formic acid in acetonitrile were used in the following gradient program: 0–1 min (5% B), 2.0–4.0 min (20% B), 8.0–9.5 min (70% B), and 10.0–11.0 min (5% B). The MS source conditions were as follows: gas temperature 350 °C, gas flow 9 L min−1, nebulizer 35 psi, sheath gas temperature 380 °C, sheath gas flow 12 L min−1, capillary 2500 V, and nozzle voltage 0 V. Selected MRM transitions were followed for each compound: protocatechuic acid (153.0 => 109.0, 91.0), p-hydroxybenzoic acid (137.0 => 108.0, 92.0), caffeic acid (179.0 => 135.0, 107.0), chlorogenic acid (353.1 => 191.0, 127.0), t-cinnamic acid (147.1 => 103.0, 77.0), ferulic acid (193.1 => 134.1, 178.0), gallic acid (169.0 => 125.0, 119.0), p-coumaric acid (163.1 => 119.0, 104.9), salicylic acid (137.0 => 93.0, 65.0), syringic acid (197.1 => 182.0, 123.0), and vanillic acid (167.0 => 152.0, 108.0) [14 (link)]. A representative chromatogram is shown in Figure 2.
+ Open protocol
+ Expand
5

Enzymatic Kinetics of Human Recombinant MAO-A and MAO-B

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hrMAO-A and hrMAO-B enzymes were purchased from Sigma-Aldrich (St. Louis, MO, USA). The reaction mixture contained hrMAO-A (2.5 µg/mL protein final concentration) or hrMAO-B (6.25 µg/mL protein final concentration) enzyme and tested compound in final concentration of 1 and 10 µM in 50 mM potassium phosphate buffer with 20% (v/v) glycerol (pH 7.5). The mixture was pre-incubated at 37 °C for 5 min and subsequently substrate kynuramine was added to the final concentration of 60 µM in the case of hrMAO-A and 30 µM in the case of hrMAO-B. The final volume of reaction mixture was 0.1 mL. The whole reaction mixture was incubated at 37 °C for 30 min. The reaction was stopped by the addition of 200 µL acetonitrile/methanol mixture (ratio 1:1) and cooling down to 0 °C. The sample was then centrifuged (16,500× g) for 10 min. The deamination product of kynuramine formed during the enzymatic reaction 4-hydroxyquinoline (4-HQ) was determined by HPLC–MS on a 2.1 mm × 50 mm, 1.8 µm Zorbax RRHD Eclipse plus C18 column (Agilent) by using a 6470 Series Triple Quadrupole mass spectrometer (Agilent) (electrospray ionisation—positive ion mode). Three MRM transitions were followed for kynuramine (165.1 => 30.2, 165.1 => 118.0, 165.1 => 136.0) and 4-HQ (146.1 => 51.1, 146.1 => 77.0, 146.1 => 91.0). Eluents: (A) 0.1% formic acid in water; (B) 0.1% formic acid in acetonitrile.
+ Open protocol
+ Expand
6

Quantification of Phenolic Compounds by UHPLC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MS analysis of phenolic acids and flavonoids was performed on UHPLC on a 2.1 × 50 mm, 1.8 µm Zorbax RRHD Eclipse plus C18 column (Agilent) with a 6470 Series Triple Quadrupole mass spectrometer (Agilent) (electrospray ionization—negative ion mode) as a detector (Santa Clara, CA, USA). The source parameters are reported in Table 2. Eluents: (A) 0.05% formic acid in water and (B) 0.05% formic acid in acetonitrile were used in the following gradient program: 0–1 min (5% B), 2.0–4.0 min (20% B), 8.0–9.5 min (70% B), 10.0–11.0 min (5% B). Selected MRM transitions were followed for each compound: Caffeic acid (179.0 = > 135.0, 107.0), vanillic acid (167.0 = > 152.0, 108.0), syringic acid (197.1 = >182.0, 123.0), p-coumaric acid (163.1 = > 119.0, 104.9), ferulic acid (193.1 = > 134.1, 178.0), chlorogenic acid (353.1 = > 191.0, 127.0), kaempferol (185.1 = > 1185.0, 239.0), luteolin (285.1 = > 133.0, 151.0), quercetin (301.0 = > 151.0, 179.0) [44 (link)]. Caffeic acid (≥ 98%), vanillic acid (≥ 97%), syringic acid (≥ 95%), p-coumaric acid (≥ 98%), ferulic acid (≥ 99%), and quercetin (≥ 95%) were purchased from Sigma-Aldrich (Steinheim, Germany). Kaempferol (≥ 97%) and luteolin (≥ 98%) were purchased from Extrasynthése (Genay Cedex, France).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!